SCOPINARO, NICOLA
 Distribuzione geografica
Continente #
EU - Europa 25.450
Totale 25.450
Nazione #
IT - Italia 25.450
Totale 25.450
Città #
Genova 19.791
Rapallo 3.284
Genoa 2.272
Vado Ligure 64
Bordighera 39
Totale 25.450
Nome #
LA RESEZIONE GASTRICA CON GASTROENTEROANASTOMOSI SECONDO ROUX PER LA TERAPIA CHIRURGICA DELL'ULCERA GASTRICA E DUODENALE. 180
Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI <35 kg/m2. 179
Early reduction of matrix metalloproteinase-8 serum levels is associated with leptin drop and predicts diabetes remission after bariatric surgery 170
Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies. 152
Biliopancreatic diversion for obesity: state of the art. 152
Biliopancreatic diversion 151
Effect of biliopancreatic diversion on hypertension in severely obese patients. 150
Three-factor Eating Questionnaire and Eating Disorder Inventory in the evaluation of psychological traits and emotional reactivity in obese patients 146
Alexithymia and eating behaviour in severely obese patients. 143
High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion 142
Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver Damage 139
Type 2 diabetes and weight loss following biliopancreatic diversion for obesity. 138
BILIO-PANCREATIC BYPASS FOR OBESITY: II. INITIAL EXPERIENCE IN MAN. 137
A 15-year evaluation of biliopancreatic diversion according to the Bariatric Analysis Reporting Outcome System (BAROS) 134
Tissue specificity in fasting glucose utilization in slightly obese diabetic patients submitted to bariatric surgery. 126
Thirteen years of follow-up in patients with adjustable silicone gastric banding for obesity: weight loss and constant rate of late specific complications. 125
Bariatric surgery in adolescents: a long-term follow-up study 124
Quality of life in obese subjects following biliopancreatic diversion. 123
Physical Activity After Surgically Obtained Weight Loss: Study with a SenseWear Armband in Subjects Undergoing Biliopancreatic Diversion 123
Three factor eating questionnaire and eating disorder inventory in the evaluation of psychological traits and emotional reactivity in obese persons 122
Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35 122
Does Biliopancreatic Diversion Carry Increased Risk for Colorectal Cancer? A Cohort Study 120
Interdisciplinary European guidelines for surgery for severe (morbid) obesity. 120
Type 2 Diabetes Remission and Control in Overweight and in Mildly Obese Diabetic Patients at Long-Term Follow-Up After Biliopancreatic Diversion 120
BEHAVIORAL APPROACH TO PROMOTE EATING HABITS AND LIFESTYLE CHANGES FOLLOWING GASTRIC CHANGES FOR OBESITY 118
A comparison of a personal series of biliopancreatic diversion and literaturedata on gastric bypass help to explain the mechanisms of resolution of type 2diabetes by the two operations. 118
WERNICKE-KORSAKOFF ENCEPHALOPATHY FOLLOWING BILIOPANCREATIC DIVERSION 118
Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity 117
Gastric cancer and Roux-en-Y gastric bypass. 116
Role of preoperative Multitest findings on predicting postoperative infectiouscomplications. 116
Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss. 116
Relationships of serum leptin to clinical and anthropometric findings in obese patients. 115
Changes in serum ghrelin concentration following biliopancreatic diversion for obesity. 115
Insulin-like growth factor-I in human malnutrition: relationship with some body composition and nutritional parameters. 115
10 YEARS EXPERIENCE WITH BILIOPANCREATIC DIVERSION (BPD) 115
The long-term impact of biliopancreatic diversion on glycemic control in the severely obese with type 2 diabetes mellitus in relation to preoperative duration of diabetes. 115
Colorectal cancer after biliopancreatic diversion for obesity 114
Orally-administered Serum Ranitidine Concentration after BiliopancreaticDiversion for Obesity. 114
Short-term liver function after biliopancreatic diversion. 114
[Role of carbohydrates in the diet of gout patients]. 113
Intraluminal penetration of the band in patients with adjustable silicone gastricbanding: radiological findings. 113
Beta-cell function improvement after biliopancreatic diversion in subjects withtype 2 diabetes and morbid obesity. 113
Radiology of patients with vertical banded gastroplasty. 113
Preoperative resting energy expenditure does not predict weight loss and maintenance after vertical banded gastroplasty. 112
A new approach to the fashioning of the gastroenteroanastomosis in laparoscopicstandard biliopancreatic diversion. 112
Prediction of Diabetes Remission at Long Term Following Biliopancreatic Diversion 112
[A case of severe obesity treated jejunoileal bypass. 1-year clinical course]. 111
The Effects of Biliopancreatic Diversion on Type 2 Diabetes Mellitus in Patients with Mild Obesity (BMI 30-35 kg/m2) and Simple Overweight (BMI 25-30 kg/m 2) A Prospective Controlled Study. 111
Binge eating in massively obese patients undergoing bariatric surgery. 111
Biliopancreatic diversion for obesity at eighteen years 111
CLINICAL USE OF PARTIAL BILIOPANCREATIC BYPASS FOR OBESITY. DETAILS OF OPERATIVE TECHNIQUE AND FOLLOW-UP MANAGEMENT. 110
Biliopancreatic diversion reduces QT interval and dispersion in severely obese patients. 109
Resting Energy Expenditure in long-term postobese subjects after weight normalization by dieting or biliopancreatic diversion 108
Editors' comment: bariatrics and diabetes meta-analysis. 108
Serum leptin concentration in obese patients with binge eating disorder. 108
Long-term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non-morbidly obese patients. 108
Thirty-five years of biliopancreatic diversion: notes on gastrointestinal physiology to complete the published information useful for a better understanding and clinical use of the operation. 108
Eating Disorder Inventory in the assessment of psychosocial status in the obese patients prior to and at long term following biliopancreatic diversion for obesity 108
Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35kg/m2: an integrative review of early studies. 107
Baseline neutrophil-to-lymphocyte ratio is associated with long-term T2D remission after metabolic surgery 107
[Aspects ofneurohypophysial function in the course of hyperthyroidism]. 106
Interdisciplinary European guidelines on surgery of severe obesity. 106
Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and cardiovascular parameters. 105
Why the Operation I Prefer is Biliopancreatic Diversion (BPD). 105
HAIR AND PLASMA ZINC LEVELS FOLLOWING EXCLUSION OF BILIOPANCREATIC SECRETIONS FROM FUNCTIONING GASTROINTESTINAL TRACT IN HUMANS. 105
Night eating and binge eating disorder in obese patients. 105
Biliopancreatic diversion: mechanisms of action and long-term results. 104
BILIOPANCREATIC DIVERSION 103
Body composition and energy expenditure in obese patients prior to and following biliopancreatic diversion for obesity. 103
Effects of Gastric Bypass on Type 2. Diabetes in Patients with BMI 30 to 35 103
Pregnancy in Formerly Type 2 Diabetes Obese WomenFollowing Biliopancreatic Diversion for Obesity 102
Body image and body weight in obese patients 102
[Orotic acid and hyperuricemia caused by fructose] 101
Leptin and HDL-cholesterol in non-diabetic normotensive subjects. 101
Laparoscopic standard biliopancreatic diversion: technique and preliminaryresults. 101
Intravenous nutritional support in pregnancy. Experience followingbiliopancreatic diversion. 101
Obese binge eaters: metabolic characteristics, energy expenditure and dieting 100
In vivo evaluation of immunological status after biliopancreatic bypass. 100
Small-intestinal and colonic changes after biliopancreatic bypass for morbidobesity. 100
An invitation to our medical colleagues: work with us. 100
Energy and nitrogen absorption after biliopancreatic diversion 100
INTRALUMINAL PENETRATION OF THE BAND IN PATIENTS WITH ADJUSTABLE SILICONE GASTRIC BAMDING: REDIOLOGICAL FINDINGS 99
Interdisciplinary European guidelines on metabolic and bariatric surgery. 99
Interdisciplinary European Guidelines on metabolic and bariatric surgery 99
Short-term changes in serum leptin concentration following biliopancreatic diversion 98
[Action of parathormone on the urinary excretion of mono- and bivalent cations in man]. 98
Can a protocol for glycaemic control improve type 2 diabetes outcomes aftergastric bypass? 98
Satiety after vertical banded gastroplasty 98
Sub-clinical organ damage in hypertension and obesity 98
BONE HISTOMORPHOMETRY AND VITAMIN D STATUS AFTER BILIOPANCREATIC BYPASS FOR OBESITY. 97
Body image in binge eating disorder. 96
Magnetic resonance spectroscopy facilitates assessment of intramyocellular lipid changes: a preliminary short-term study following biliopancreatic diversion. 96
Plasma ghrelin concentratin in the short-term following biliopancreaticdiversion. 96
Pregnancies in an 18-year follow-up after biliopancreatic diversion 96
PROTEIN-MALNUTRITION AFTER BILIOPANCREATIC DIVERSION (BPD) 95
TWO YEARS OF CLINICAL EXPERIENCE WITH BILIO-PANCREATIC BYPASS FOR OBESITY 95
Pouch diverticula after vertical-banded gastroplasty. 95
Biliopancreatic Diversion. 93
Are BPD subjects at increase risk of colon cancer? 93
'Simple' form of Caroli's disease 91
Totale 11.370
Categoria #
all - tutte 67.811
article - articoli 65.923
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.888
Totale 135.622


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.667 0 164 385 364 594 598 1.174 322 575 1.402 777 312
2020/20211.671 138 85 190 138 58 217 106 102 236 124 140 137
2021/20223.753 66 358 226 525 162 204 295 814 132 373 96 502
2022/20233.930 420 178 27 432 628 784 8 380 655 22 335 61
2023/20241.592 103 227 18 185 114 346 38 82 83 48 117 231
2024/2025137 101 36 0 0 0 0 0 0 0 0 0 0
Totale 25.517